Latest News
June 13, 2008 — Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis |
![]() |
News
- Read Gilead's 2007 Annual Report
- Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
- Gilead Sciences to Present at the 29th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11
- U.S. Patent Office Confirms Second of Four Viread(R) Patents
- View all news
Events
- July 17, 2008
Gilead's Second Quarter 2008 Financial Results
Foster City, CA - August 3 - 8, 2008
XVII International AIDS Conference
Mexico City, Mexico - View all events



